Augmented Reality Treadmill Training in Patients With Parkinson's Disease: a Randomized Controlled Study
Trial ID: NCT04108741
Interventional - Phase Unknown - Terminated
Gait disorder is a disabling symptom in Parkinson's disease (PD) affecting all patients during the course. Three methods of treadmill training (TT) will be compared to assess additional augmented reality (AR), or additional dual task (DT). AR TT, DT TT, and TT alone applied over 3 weeks at each day will be compared for their impact on falls, walking, freezing and attention for 3 months in a double blinded randomized controlled trial during regular neurorehabilitation.
Conditions
Interventions
- C-Mill augmented reality treadmill training
Eligibility
Inclusion criteria
- Informed Consent as documented by signature
- Parkinson“s disease without dementia and hallucination
- at least one fall within the past 3 months or postural instability
- Gait disorder
- Hoehn and Yahr stages II-IV
- able to perform the treadmill therapy during a study
Exclusion criteria
- Contraindications to treadmill therapy (e.g. hip fracture)
- Dementia as defined by an Montreal cognitive assessment (MOCA) \< 20
Sponsor
Klinik Valens
Source: ClinicalTrials.gov
Search more clinical trials on myTomorrows